Suppr超能文献

在接受积极利尿治疗的急性心力衰竭患者中,肾功能恶化与肾小管损伤无关。

Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.

机构信息

Sections of Cardiovascular Medicine (T.A., K.J., V.S.R., J.M.T.).

Section of Heart Failure and Cardiac Transplantation, The Cleveland Clinic, OH (W.H.W.T.).

出版信息

Circulation. 2018 May 8;137(19):2016-2028. doi: 10.1161/CIRCULATIONAHA.117.030112. Epub 2018 Jan 19.

Abstract

BACKGROUND

Worsening renal function (WRF) in the setting of aggressive diuresis for acute heart failure treatment may reflect renal tubular injury or simply indicate a hemodynamic or functional change in glomerular filtration. Well-validated tubular injury biomarkers, -acetyl-β-d-glucosaminidase, neutrophil gelatinase-associated lipocalin, and kidney injury molecule 1, are now available that can quantify the degree of renal tubular injury. The ROSE-AHF trial (Renal Optimization Strategies Evaluation-Acute Heart Failure) provides an experimental platform for the study of mechanisms of WRF during aggressive diuresis for acute heart failure because the ROSE-AHF protocol dictated high-dose loop diuretic therapy in all patients. We sought to determine whether tubular injury biomarkers are associated with WRF in the setting of aggressive diuresis and its association with prognosis.

METHODS

Patients in the multicenter ROSE-AHF trial with baseline and 72-hour urine tubular injury biomarkers were analyzed (n=283). WRF was defined as a ≥20% decrease in glomerular filtration rate estimated with cystatin C.

RESULTS

Consistent with protocol-driven aggressive dosing of loop diuretics, participants received a median 560 mg IV furosemide equivalents (interquartile range, 300-815 mg), which induced a urine output of 8425 mL (interquartile range, 6341-10 528 mL) over the 72-hour intervention period. Levels of -acetyl-β-d-glucosaminidase and kidney injury molecule 1 did not change with aggressive diuresis (both >0.59), whereas levels of neutrophil gelatinase-associated lipocalin decreased slightly (-8.7 ng/mg; interquartile range, -169 to 35 ng/mg; <0.001). WRF occurred in 21.2% of the population and was not associated with an increase in any marker of renal tubular injury: neutrophil gelatinase-associated lipocalin (=0.21), -acetyl-β-d-glucosaminidase (=0.46), or kidney injury molecule 1 (=0.22). Increases in neutrophil gelatinase-associated lipocalin, -acetyl-β-d-glucosaminidase, and kidney injury molecule 1 were paradoxically associated with improved survival (adjusted hazard ratio, 0.80 per 10 percentile increase; 95% confidence interval, 0.69-0.91; =0.001).

CONCLUSIONS

Kidney tubular injury does not appear to have an association with WRF in the context of aggressive diuresis of patients with acute heart failure. These findings reinforce the notion that the small to moderate deteriorations in renal function commonly encountered with aggressive diuresis are dissimilar from traditional causes of acute kidney injury.

摘要

背景

急性心力衰竭治疗中积极利尿时肾功能恶化(WRF)可能反映肾小管损伤,或者仅表明肾小球滤过的血流动力学或功能变化。现在有经过良好验证的肾小管损伤生物标志物 - 乙酰-β-D-氨基葡萄糖苷酶、中性粒细胞明胶酶相关脂质运载蛋白和肾损伤分子 1,可定量评估肾小管损伤程度。ROSE-AHF 试验(肾脏优化策略评估-急性心力衰竭)为研究急性心力衰竭积极利尿时 WRF 的机制提供了一个实验平台,因为 ROSE-AHF 方案规定所有患者均接受大剂量袢利尿剂治疗。我们试图确定在积极利尿和其与预后的关联中,肾小管损伤生物标志物是否与 WRF 相关。

方法

对多中心 ROSE-AHF 试验中具有基线和 72 小时尿液肾小管损伤生物标志物的患者进行分析(n=283)。WRF 定义为胱抑素 C 估计肾小球滤过率下降≥20%。

结果

与方案驱动的积极袢利尿剂剂量一致,参与者接受中位数为 560mg IV 呋塞米等效物(四分位距,300-815mg),在 72 小时干预期间诱导尿量为 8425mL(四分位距,6341-10528mL)。在积极利尿过程中,-乙酰-β-D-氨基葡萄糖苷酶和肾损伤分子 1 的水平没有变化(均>0.59),而中性粒细胞明胶酶相关脂质运载蛋白水平略有下降(-8.7ng/mg;四分位距,-169 至 35ng/mg;<0.001)。人群中发生 WRF 的比例为 21.2%,与任何肾小管损伤标志物的增加均无关:中性粒细胞明胶酶相关脂质运载蛋白(=0.21)、-乙酰-β-D-氨基葡萄糖苷酶(=0.46)或肾损伤分子 1(=0.22)。中性粒细胞明胶酶相关脂质运载蛋白、-乙酰-β-D-氨基葡萄糖苷酶和肾损伤分子 1 的增加与生存改善呈相反关系(调整后的危险比,每增加 10%分位数增加 0.80;95%置信区间,0.69-0.91;=0.001)。

结论

在急性心力衰竭患者积极利尿的情况下,肾脏管状损伤似乎与 WRF 无关。这些发现强化了这样的观念,即积极利尿时肾功能的小到中度恶化与传统的急性肾损伤原因不同。

相似文献

引用本文的文献

4
Mechanisms of Congestion in Acute Decompensated Heart Failure.急性失代偿性心力衰竭中充血的机制
Cardiorenal Med. 2025;15(1):544-551. doi: 10.1159/000544929. Epub 2025 Jun 28.
5
How to Enhance Cardiorenal Benefits in Patients With Chronic Heart Failure?如何增强慢性心力衰竭患者的心肾获益?
Int J Heart Fail. 2025 Apr 4;7(2):58-78. doi: 10.36628/ijhf.2025.0004. eCollection 2025 Apr.

本文引用的文献

1
Use of the National Heart, Lung, and Blood Institute Data Repository.美国国立心肺血液研究所数据储存库的使用。
N Engl J Med. 2017 May 11;376(19):1849-1858. doi: 10.1056/NEJMsa1603542. Epub 2017 Mar 29.
4
Acute kidney injury: a problem of definition.急性肾损伤:定义问题
Lancet. 2017 Feb 25;389(10071):779-781. doi: 10.1016/S0140-6736(17)30543-3.
7
Unique Transcriptional Programs Identify Subtypes of AKI.独特的转录程序可识别急性肾损伤的亚型。
J Am Soc Nephrol. 2017 Jun;28(6):1729-1740. doi: 10.1681/ASN.2016090974. Epub 2016 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验